Report overview
Gene therapy provides a novel strategy for targeting abnormalities in heart cells that adversely affect heart function.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy For Heart Failure, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy For Heart Failure. This report contains market size and forecasts of Gene Therapy For Heart Failure in global, including the following market information:
Global Gene Therapy For Heart Failure Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Gene Therapy For Heart Failure market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Gene Modification Segment to Reach $ Million by 2035, with a % CAGR in next six years.
The global key manufacturers of Gene Therapy For Heart Failure include Askbio, RENOVACORINC, Uniqure, DINAQOR, PRECIGEN, Heartseed, Cardior, NOVARTIS and Blue Rock, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Therapy For Heart Failure companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapy For Heart Failure Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Gene Therapy For Heart Failure Market Segment Percentages, by Type, 2022 (%)
Gene Modification
Gene Replacement
Others
Global Gene Therapy For Heart Failure Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Gene Therapy For Heart Failure Market Segment Percentages, by Application, 2022 (%)
Hospital
Laboratory
Others
Global Gene Therapy For Heart Failure Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Gene Therapy For Heart Failure Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Therapy For Heart Failure revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene Therapy For Heart Failure revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Askbio
RENOVACORINC
Uniqure
DINAQOR
PRECIGEN
Heartseed
Cardior
NOVARTIS
Blue Rock
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Therapy For Heart Failure, market overview.
Chapter 2: Global Gene Therapy For Heart Failure market size in revenue.
Chapter 3: Detailed analysis of Gene Therapy For Heart Failure company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Therapy For Heart Failure in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
